228 related articles for article (PubMed ID: 24934786)
1. Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.
Sheppard VB; Faul LA; Luta G; Clapp JD; Yung RL; Wang JH; Kimmick G; Isaacs C; Tallarico M; Barry WT; Pitcher BN; Hudis C; Winer EP; Cohen HJ; Muss HB; Hurria A; Mandelblatt JS
J Clin Oncol; 2014 Aug; 32(22):2318-27. PubMed ID: 24934786
[TBL] [Abstract][Full Text] [Related]
2. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients.
Hershman DL; Kushi LH; Shao T; Buono D; Kershenbaum A; Tsai WY; Fehrenbacher L; Gomez SL; Miles S; Neugut AI
J Clin Oncol; 2010 Sep; 28(27):4120-8. PubMed ID: 20585090
[TBL] [Abstract][Full Text] [Related]
3. Cognitive function and discontinuation of adjuvant hormonal therapy in older breast cancer survivors: CALGB 369901 (Alliance).
Bluethmann SM; Alfano CM; Clapp JD; Luta G; Small BJ; Hurria A; Cohen HJ; Sugarman S; B Muss H; Isaacs C; Mandelblatt JS
Breast Cancer Res Treat; 2017 Oct; 165(3):677-686. PubMed ID: 28653250
[TBL] [Abstract][Full Text] [Related]
4. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy.
Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL
Breast J; 2012; 18(3):203-13. PubMed ID: 22487337
[TBL] [Abstract][Full Text] [Related]
5. Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance).
Mandelblatt JS; Cai L; Luta G; Kimmick G; Clapp J; Isaacs C; Pitcher B; Barry W; Winer E; Sugarman S; Hudis C; Muss H; Cohen HJ; Hurria A
Breast Cancer Res Treat; 2017 Jul; 164(1):107-117. PubMed ID: 28364214
[TBL] [Abstract][Full Text] [Related]
6. Five-Year Adjuvant Endocrine Therapy Adherence Trajectories Among Women With Breast Cancer: A Nationwide French Study Using Administrative Data.
Lailler G; Memoli V; Le Bihan Benjamin C; Ben Diane MK; Lauzier S; Mancini J; Bousquet PJ; Bouhnik AD
Clin Breast Cancer; 2021 Aug; 21(4):e415-e426. PubMed ID: 33745868
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.
Ji J; Sun CL; Cohen HJ; Synold T; Muss H; Sedrak MS
J Clin Oncol; 2023 Jan; 41(2):307-315. PubMed ID: 36126235
[TBL] [Abstract][Full Text] [Related]
8. Racial Differences in Adjuvant Endocrine Therapy Use and Discontinuation in Association with Mortality among Medicare Breast Cancer Patients by Receptor Status.
Farias AJ; Du XL
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1266-1275. PubMed ID: 28515111
[No Abstract] [Full Text] [Related]
9. Adjuvant hormonal therapy use among insured, low-income women with breast cancer.
Kimmick G; Anderson R; Camacho F; Bhosle M; Hwang W; Balkrishnan R
J Clin Oncol; 2009 Jul; 27(21):3445-51. PubMed ID: 19451445
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC
Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Discontinuation of Adjuvant Hormone Therapy in Patients With Breast Cancer.
He W; Fang F; Varnum C; Eriksson M; Hall P; Czene K
J Clin Oncol; 2015 Jul; 33(20):2262-9. PubMed ID: 26033800
[TBL] [Abstract][Full Text] [Related]
12. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.
Kroenke CH; Hershman DL; Gomez SL; Adams SR; Eldridge EH; Kwan ML; Ergas IJ; Kubo A; Kushi LH
Breast Cancer Res Treat; 2018 Aug; 170(3):623-631. PubMed ID: 29671113
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant therapy use among Appalachian breast cancer survivors.
Tan X; Marshall VD; Anderson RT; Donohoe J; Camacho F; Balkrishnan R
Medicine (Baltimore); 2015 Jul; 94(26):e1071. PubMed ID: 26131828
[TBL] [Abstract][Full Text] [Related]
14. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer.
Hershman DL; Shao T; Kushi LH; Buono D; Tsai WY; Fehrenbacher L; Kwan M; Gomez SL; Neugut AI
Breast Cancer Res Treat; 2011 Apr; 126(2):529-37. PubMed ID: 20803066
[TBL] [Abstract][Full Text] [Related]
15. Five-year patterns of adjuvant hormonal therapy use, persistence, and adherence among insured women with early-stage breast cancer.
Nekhlyudov L; Li L; Ross-Degnan D; Wagner AK
Breast Cancer Res Treat; 2011 Nov; 130(2):681-9. PubMed ID: 21842245
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer.
Jhawar SR; Alpert N; Taioli E; Sayan M; Bazan J; Park KU; Stover D; Cherian M; White J; Haffty B; Ohri N
Cancer Med; 2020 Nov; 9(22):8345-8354. PubMed ID: 32942344
[TBL] [Abstract][Full Text] [Related]
17. Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).
Neugut AI; Hillyer GC; Kushi LH; Lamerato L; Leoce N; Nathanson SD; Ambrosone CB; Bovbjerg DH; Mandelblatt JS; Magai C; Tsai WY; Jacobson JS; Hershman DL
Breast Cancer Res Treat; 2012 Jul; 134(1):419-28. PubMed ID: 22527111
[TBL] [Abstract][Full Text] [Related]
18. Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.
Murphy CC; Bartholomew LK; Carpentier MY; Bluethmann SM; Vernon SW
Breast Cancer Res Treat; 2012 Jul; 134(2):459-78. PubMed ID: 22689091
[TBL] [Abstract][Full Text] [Related]
19. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study.
Greenlee H; Neugut AI; Falci L; Hillyer GC; Buono D; Mandelblatt JS; Roh JM; Ergas IJ; Kwan ML; Lee M; Tsai WY; Shi Z; Lamerato L; Kushi LH; Hershman DL
JAMA Oncol; 2016 Sep; 2(9):1170-6. PubMed ID: 27243607
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence.
Lee C; Check DK; Manace Brenman L; Kushi LH; Epstein MM; Neslund-Dudas C; Pawloski PA; Achacoso N; Laurent C; Fehrenbacher L; Habel LA
Breast Cancer Res Treat; 2020 Feb; 180(1):219-226. PubMed ID: 31975315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
